T

Active Director Director DIN 05325908
DIN 05325908 First appointment Aug 2012 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2012
Shareholding value •••• Premium profile

About Tripuresh

Data last updated:

Tripuresh is a Director at Galaxyline Biocare Private Limited (since 2012). The company operates in Chemicals. Galaxyline Biocare Private Limited reported revenue of ₹1.2 Lakh (FY 2019).

DIN 05325908
Primary Designation Director
Industry Chemicals
First Appointment 06 Aug 2012
Oldest Company Age 14 yrs
Largest company Galaxyline Biocare Private Limited · ₹1.2 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Galaxyline Biocare Private Limited U74120UP2012PTC051809
Director06 Aug 20122012₹1.2 Lakh (FY 2019)Active

Board colleagues of Tripuresh

Directorship timeline

Open interactive timeline →
Galaxyline Biocare Private Limited
Premium access

Shareholding and investment profile for Tripuresh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tripuresh

Tripuresh currently holds 1 directorship: Galaxyline Biocare Private Limited (Director, since 06 Aug 2012, revenue ₹1.2 Lakh (FY 2019)).

Tripuresh was first appointed on 06 Aug 2012 as Director at Galaxyline Biocare Private Limited.

The current boards of Tripuresh's companies include Hifzurrehman (Galaxyline Biocare Private Limited), Mohammad Rafeek (Galaxyline Biocare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available